Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Don't Let Poor Tablet Lubrication Detour Your Formulation | Contract Pharma

What are you searching for?

Sign in
Infographics

Don’t Let Poor Tablet Lubrication Detour Your Formulation

Compritol® 888 ATO (Glyceryl Dibehenate) Keeps You Moving

Released By Gattefossé

Formulation challenges can feel like roadblocks — from API incompatibility and dissolution delays to safety concerns and inconsistent tablet performance. When you face obstacles in tablet lubrication, you need a reliable, proven option to keep your project on track.

In this infographic from Gattefossé, you will learn how Compritol® 888 ATO, a trusted excipient for over 50 years, helps you navigate common tablet lubrication detours that derail solid dose development, including:

  • API Incompatibility
  • Inconsistent Dissolution
  • Overblending Challenges
  • Safety and Nitrosamine Concerns

Whether you’re developing products for adults or pediatrics, Compritol® 888 ATO provides the safety, compatibility, and reliability to ensure you achieve your formulation goals.

Ready to reach the finish line?

Click the button below to download the infographic and learn how Gattefossé helps you clear the path to a successful oral tablet formulation.

Request more information from Gattefossé

Request more information from Gattefossé

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics